Months after developing one of the nation’s first saliva-based coronavirus tests, researchers at Rutgers University are closing in on their next breakthrough: A saliva test for both COVID-19 and the flu. The research is being conducted at RUCDR Infinite Biologics — a unit of Rutgers’ Human Genetics Institute of New Jersey — the same lab that gained federal approval in April for a coronavirus saliva test. The test allows people to collect their own samples at home and send them to be processed. Andrew Brooks, chief operating officer and director of technology development at RUCDR, said the lab hopes to have a test approved by the fall. And just in time for flu season. To read the full story.
Home / News / Rutgers researchers eye new saliva test breakthrough: A potential coronavirus and flu combo
Recent Posts
- Clinical Trials Day 2026 is May 20th – Submit an Abstract by February 13th
- Clinical trial in N.J. gives patients with incurable cancer a new chance at life.
- Entrepreneurship Lessons Coming to Introductory Engineering Courses.
- Scientists Develop Plastics That Can Break Down, Tackling Pollution.
- NJACTS Community Engagement Core COVID-19 Resources
Categories
- Community (2,430)
- Covid (996)
- CTO Events (6)
- News (3,077)
- Pilots (21)